Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?
Intellia Therapeutics Ownership Summary
Intellia Therapeutics is owned by 95.18% institutional investors, 4.80% insiders, and 0.02% retail investors. Ark investment management is the largest institutional shareholder, holding 12.55% of NTLA shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 8.11% of its assets in Intellia Therapeutics shares.
NTLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Intellia Therapeutics | 95.18% | 4.80% | 0.02% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 306.69% | 11.10% | -217.79% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 13.02M | 12.55% | $122.11M |
| Vanguard group | 10.19M | 10.09% | $118.82M |
| Blackrock | 9.60M | 10.05% | $214.79M |
| Blackrock funding, inc. /de | 10.03M | 9.67% | $94.05M |
| State street | 4.36M | 4.57% | $97.64M |
| Regeneron pharmaceuticals | 3.70M | 3.57% | $34.73M |
| Baker bros. advisors lp | 2.68M | 2.58% | $25.10M |
| Nikko asset management americas | 2.67M | 2.58% | $25.00M |
| Morgan stanley | 2.34M | 2.45% | $52.32M |
| Geode capital management | 2.39M | 2.37% | $27.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Discovery value fund | 561.56K | 3.76% | $6.55M |
| Contrarius investment management | 1.92M | 2.68% | $42.87M |
| Regeneron pharmaceuticals | 3.70M | 2.34% | $34.73M |
| Ark investment management | 13.02M | 0.90% | $122.11M |
| Orchard capital management | 79.21K | 0.82% | $742.97K |
| Generali investments towarzystwo funduszy inwestycyjnych | 80.00K | 0.73% | $1.38M |
| Iq eq fund management (ireland) | 494.47K | 0.58% | $8.54M |
| Birchview capital, lp | 60.00K | 0.56% | $562.80K |
| Himension capital (singapore) pte. | 729.42K | 0.53% | $6.84M |
| Avidity partners management lp | 232.00K | 0.43% | $2.18M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 2.68M | 0.24% | 2.03M |
| Ubs group | 1.74M | 0.00% | 1.46M |
| Goldman sachs group | 2.03M | 0.00% | 1.00M |
| Two sigma advisers, lp | 2.00M | 0.05% | 970.70K |
| Two sigma investments, lp | 1.84M | 0.05% | 863.36K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.95M |
| Capital investors | - | - | -3.78M |
| Casdin capital | - | - | -2.00M |
| Alliancebernstein | 265.32K | 0.00% | -1.93M |
| Pictet asset management sa | - | - | -1.39M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Graham capital management | 234.76K | 0.03% | 234.76K | $2.20M |
| Avidity partners management lp | 232.00K | 0.43% | 232.00K | $2.18M |
| Twinbeech capital lp | 137.76K | 0.03% | 137.76K | $1.29M |
| Y-intercept (hong kong) | 137.29K | 0.06% | 137.29K | $2.37M |
| Birchview capital, lp | 60.00K | 0.56% | 60.00K | $562.80K |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -1.00 |
| Global financial private client | -1.00 |
| Activest wealth management | -1.00 |
| Richard w. paul & associates | -2.00 |
| Jfs wealth advisors | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 290 | -7.05% | 98,735,343 | -2.49% | 95 | 0.99% | 146 | -0.68% | 85 | -10.53% |
| Mar 31, 2025 | 6 | -98.05% | 3,804,135 | -96.17% | 3 | 0.04% | 3 | -98.41% | 1 | -98.55% |
| Dec 31, 2024 | 286 | -2.39% | 92,252,291 | -1.01% | 91 | 1.07% | 178 | 17.11% | 61 | -27.38% |
| Sep 30, 2024 | 290 | -5.54% | 93,104,860 | 3.35% | 92 | 1.07% | 150 | -7.41% | 84 | -4.55% |
| Jun 30, 2024 | 302 | 0.67% | 90,028,919 | -0.69% | 94 | 1.05% | 160 | 5.26% | 86 | -2.27% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 8.71M | 8.11% | 966.00 |
| ARK Innovation ETF | 8.28M | 7.71% | 61.21K |
| American Funds SMALLCAP World A | 3.78M | 3.65% | 3.78M |
| Vanguard US Total Market Shares ETF | 3.17M | 3.06% | 299.88K |
| Vanguard Total Stock Mkt Idx Inv | 3.17M | 2.95% | -70.23K |
| ARK Genomic Revolution ETF | 2.89M | 2.69% | -10.31K |
| ARK Genomic Revolution | 2.88M | 2.68% | -220.20K |
| Vanguard Small Cap Index | 2.51M | 2.34% | -16.78K |
| iShares Russell 2000 ETF | 2.48M | 2.31% | - |
| Nikko AM ARK Disruptive Innovation A USD | 1.76M | 1.70% | -68.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 01, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell | $538.78 |
| Oct 01, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell | $32.52K |
| Aug 20, 2025 | CHASE WILLIAM J | - | Buy | $1.00M |
| Jul 23, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | Sell | $104.62K |
| Jul 01, 2025 | Clark Eliana | EVP, Chief Technical Officer | Sell | $10.04K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | 1 | 4 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | 1 |
NTLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools